|
Market Cap (6-Jul) $758,238,016 (475th) |
Close (30-Jun) $0.056 |
Volume (30-Jun) 1,984,515 |
Shortsold (19-Jun) 895,750 (0.15%) (396th) |
|
52w High $2.09 |
52w Low $0.90 |
P/E - |
EPS -0.11 |
PYC released this announcement to the ASX on 29 April 2022, 9:26. The announcement is marked as price sensitive, and is 9 page(s) in length and 238.74kb in size.
You can view all announcements from PYC and see how they appear on a price chart on the announcements page.
At the date of this announcement, PYC was 0.012% short sold according to ASIC data. It was ranked the 608th most shorted stock on the ASX. It is now ranked as the 396th most shorted stock on the ASX with 0.154% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from PYC | |
|---|---|
| FIRST PATIENT DOSED IN EYE DISEASE CLINICAL TRIAL | 30 June 2023, 8:17 |
| Change of Director's Interest Notice | 28 June 2023, 16:46 |
| PYC Investor Update Presentation | 16 June 2023, 8:32 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 29 April 2022, 9:26 |
| Completes FDA Pre-IND engagement - RP11 program | 23 March 2022, 12:13 |
| Q1 Investor Call Presentation | 17 March 2022, 9:24 |
| Quarterly Investor Call March 2022 | 8 March 2022, 12:12 |
You must be logged in to post a reply.
